Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hilton Hotels Corporation Common Stock (HLT) vs Medpace Holdings Inc (MEDP) Price & Performance

Hilton Hotels Corporation Common StockTrade
Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

Hilton Hotels Corporation Common Stock vs Medpace Holdings Inc — how do they compare? Hilton Hotels Corporation Common Stock trades at $323.55 (market cap $70.82B), while Medpace Holdings Inc trades at $600.35 (market cap $16.90B). The key difference: Hilton Hotels Corporation Common Stock is far larger — about 4.2× Medpace Holdings Inc's market cap, and Hilton Hotels Corporation Common Stock pays a 0.19% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.

HLTMEDP
Market Cap
$70.82B$16.90B
Sector
Consumer CyclicalTechnology
52-Week High
$350.22$620.59
52-Week Low
$256.75$393.42
Enterprise Value
$83.83B$16.52B
Dividend Yield
0.19%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hilton Hotels Corporation Common Stock

Hilton Worldwide Holdings (HLT) trades at $322.51, up 3.7% with strong earnings momentum after beating Q2 2026 estimates. The stock shows bearish technical signals but maintains solid fundamentals with revenue growth to $12.04B in 2025 and net income of $1.46B. Recent news highlights labor strikes and executive stock sales, while analyst consensus remains bullish with a $352 price target.

HLT offers growth potential from travel recovery and pipeline expansion, but faces risks from premium valuation (P/E 46.21), rising debt levels, and operational challenges. The stock trades near resistance at $316-$319, requiring strong Q3 earnings to sustain momentum amid mixed technical indicators.

Medpace Holdings Inc

MEDP trades at $600.32, down 0.35% on the day, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with Q2 2026 earnings beating estimates at $4.25 per share versus $3.98 expected, and revenue growth projected from $2.53B in 2025 to $2.8B in 2026. Recent news highlights record bookings and raised guidance, though valuation ratios remain elevated with a P/E of 35.58 and P/B of 38.95.

Outlook remains positive driven by earnings momentum and strong backlog visibility, but risks include premium valuation compression and ongoing legal scrutiny. Analyst consensus is cautious with 73.7% hold ratings, though institutional interest persists with California State Teachers Retirement System increasing its position by 22.1% in Q1 2026.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Hilton Hotels Corporation Common Stock

Hilton Worldwide Holdings operates 1,074,791 rooms across its 18 brands addressing the midscale through luxury segments as of Dec. 31, 2021. Hampton and Hilton are the two largest brands by total room count at 28% and 21%, respectively, as of Dec. 31, 2021. Recent brands launched over the last few years include Home2, Curio, Canopy, Tru, and Tempo. Managed and franchised represent the vast majority of adjusted EBITDA, predominantly from the Americas regions.

Read more on HLT

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP